AI assistant
Marel — Investor Presentation 2015
Oct 29, 2015
2191_rns_2015-10-29_9d74bbb8-8375-4625-858f-8fab40824e3e.pdf
Investor Presentation
Open in viewerOpens in your device viewer

Q3 2015 Presentation
October 29, 2015
iMareI
Innovation Through Partnership®
iMareI Innovation Through Partnership

Arni Oddur Thordarson, CEO
imarel Innovation Through Partnership
Strong order intake and robust operational performance
- Revenue of €189 million [Q3 2014: 188m]
- Good geographical and product mix
- Order intake of €211 million [Q3 2014: 200m]
- Adj. EBIT €24.2 million or 12.8% [Q3 2014: 9.3%]
- Adj. EBITDA €31.6 million or 16.7% [Q3 2014: 13.8%]
- Net result €14.7 million [Q3 2014: 9.8m]
- Earnings per share 2.07 eurocents [Q3 2014: 1.34]

* Refocusing costs in Q3 2015 amount to €2.0 million
imarel
Innovation Through Partnership
Order book at a good level

imarel
Innovation Through Partnership
Solid operational performance with strong cash flow

- Adj. EBIT €24.2 million or 12.8% [Q3 2014: 9.3%]
- Marel has streamlined its operations and focused its product portfolio
- Discontinued low margin business accounts for 30 million annually and is not included in the accounts since Q2 2015
- Marel has optimized its manufacturing footprint leading to improved margins
- Year to date revenue is €617 million and adj. EBIT is €78 million (12.6%) compared with €513 million and €33 million (6.4%) respectively during same period last year
- Order book has good product and geographical mix and now stands at €188 million compared with €169 million in Q3 2014
EBITDA improvement and strong cash flow has driven Net Debt/adj. EBITDA down to 1.1
imarel Innovation Through Partnership
Business overview for the first nine months of 2015
Other segments such as vegetable and cheese account for 1% of revenue

Poultry
Very strong first nine months of the year with good volume and profitability
Good mix of greenfields, modernization, and maintenance business around the globe
55% of revenue
17.8% adj. EBIT

Fish
Good first nine months of the year for Marel's fish segment
Conditions in salmon and white fish segments remain favorable
FleXicut continues to impress customers and good sales were seen in salmon filleting machines in the third quarter
17% of revenue
9.3% adj. EBIT

Meat
Good improvement in profitability compared to previous years
Good activity in third quarter with landmark orders from Mexico and China
Product mix will lead to lower profitability in Q4 than YTD
15% of revenue
9.2% adj. EBIT

Further Processing
Streamlining of activities continued with the ongoing transfer of activities from Des Moines to Gainesville
Further streamlining and investments planned to strengthen Marel's position in the convenience food market
12% of revenue
-2.6% adj. EBIT
imarel
Innovation Through Partnership

Linda Jonsdottir, CFO
Business results
marel Innovation Through Partnership
| EUR thousands | Q3 2015 | Q3 2014 | Change in % |
|---|---|---|---|
| Revenue | 189,106 | 187,931 | 0.6 |
| Gross profit before refocusing cost | 73,923 | 67,372 | 9.7 |
| as a % of revenue | 39.1 | 35.8 | |
| Before refocusing costs | |||
| Result from operations (adjusted EBIT) | 24,166 | 17,409 | 38.8 |
| as a % of revenue | 12.8 | 9.3 | |
| Adjusted EBITDA | 31,636 | 25,912 | 22.1 |
| as a % of revenue | 16.7 | 13.8 | |
| After refocusing costs | |||
| Result from operations (EBIT) | 22,206 | 16,113 | 37.8 |
| as a % of revenue | 11.7 | 8.6 | |
| EBITDA | 29,686 | 24,616 | 20.6 |
| as a % of revenue | 15.7 | 13.1 | |
| Net result | 14,698 | 9,841 | 49.3 |
| Orders received (including service revenues) | 210,940 | 200,747 | 5.1 |
| Order book | 187,722 | 169,242 | 10.9 |
imarel
Firm steps taken to improve profitability

imarel
Innovation Through Partnership
Order book grew by EUR 22 million between quarters

Order book at the end of Q3 reflects continued operations and refocused product portfolio
imarel
Innovation Through Partnership
Condensed consolidated balance sheet
ASSETS (EUR thousands)
| 30/9 2015 | 31/12 2014 | |
|---|---|---|
| Non-current assets | ||
| Property, plant and equipment | 85,155 | 96,139 |
| Goodwill | 388,811 | 387,103 |
| Other intangible assets | 105,708 | 114,916 |
| Receivables | 441 | 94 |
| Deferred income tax assets | 9,965 | 7,873 |
| 590,080 | 606,125 | |
| Current assets | ||
| Inventories | 96,210 | 88,450 |
| Production contracts | 30,390 | 29,123 |
| Trade receivables | 78,020 | 77,125 |
| Assets held for sale | 4,899 | 2,500 |
| Other receivables and prepayments | 25,928 | 23,551 |
| Cash and cash equivalents | 92,119 | 24,566 |
| 327,566 | 245,315 | |
| Total assets | 917,646 | 851,440 |
iimarel Innovation Through Partnership
Condensed consolidated balance sheet (continued)
| LIABILITIES AND EQUITY (EUR thousands) | 30/9 2015 | 31/12 2014 |
|---|---|---|
| Equity | 434,339 | 427,498 |
| LIABILITIES | ||
| Non-current liabilities | ||
| Borrowings | 223,951 | 180,278 |
| Deferred income tax liabilities | 15,499 | 11,308 |
| Provisions | 11,282 | 7,292 |
| Derivative financial instruments | 4,346 | 5,399 |
| 255,078 | 204,277 | |
| Current liabilities | ||
| Production contracts | 73,673 | 64,958 |
| Trade and other payables | 120,615 | 122,479 |
| Current income tax liabilities | 6,365 | 4,185 |
| Borrowings | 18,462 | 18,635 |
| Provisions | 9,114 | 9,408 |
| 228,229 | 219,665 | |
| Total liabilities | 483,307 | 423,942 |
| Total equity and liabilities | 917,646 | 851,440 |
imarel
Innovation Through Partnership
Q3 2015 cash flow composition and change in net debt
| Operating activities (before interest & tax) | Tax | Invest-ment activities | Free cash flow | Net finance cost | Purchase of Treasury shares | Other items* | Decrease in net debt |
|---|---|---|---|---|---|---|---|
| 1.5 million | |||||||
| 29.7 million | 4.9 million | 23.3 million | 2.9 million | 13.8 million | 0.9 million | 5.7 million |
- Tax on dividend, currency effect and change in capitalized finance charges
Anatel Innovation Through Partnership
Ample room for stimulating further growth
- Net debt /adj.EBITDA is 1.12 x EBITDA compared with target of 2-3 x EBITDA
- Marel is stimulating further revenue and operational profit growth by:
- Streamlining the business
- Continuous innovation
- Investing in the business
- In Q3 Marel acquired 10 million treasury shares for the total amount of €13.8 million. In Q2 Marel acquired 15 million treasury shares for €18.2 million.
- Marel holds 31.7 million treasury shares, whereof 6.7 million are hedged towards outstanding stock options and 25 million were acquired to use in relations with future acquisitions

iMareI Innovation Through Partnership

Arni Oddur Thordarson, CEO
Good mix of Greenfields, Modernization and Maintenance
marel Innovation Through Partnership
Modernization and standard equipment
- Investment in expansion and modernization projects picking up, especially in the Americas and in Europe

Greenfields
- Small and medium-sized greenfield projects in all segments and large-scale projects in poultry, meat and further processing in Q3 2015
Maintenance
- Marel has the largest installment base in its industry
- Recurring service and spare parts revenues increasing steadily and are currently around 40% of total revenues
imarel
Innovation Through Partnership
Strategic acquisitions and strong organic growth
- Marel shares were listed at the Icelandic Stock Exchange in 1992 with revenue of €6 million and 45 employees – focus on the fish industry
- Marel is currently a global leader in providing advanced equipment for the poultry, meat and fish industry with 4,000 employees operating in 32 countries
- Organic revenue growth has been 6% per year post Stork Food System acquisition in 2008 and earnings per share have grown 20% per year

Simpler, Smarter, Faster: 2014-2015
Full potential
Product portfolio optimized

At the customer, for the customer
Manufacturing footprint optimized
2014
Revenue growth 7.7%
Adj. EBIT €48.8 m
Free cash flow €75.5m
Cash-out cost to date €14 million compared to estimated total cash-out cost of below €25 million throughout the program
2015 year-to-date
Revenue €617m
Adj. EBIT €77.7m
Free cash flow €70.6m
2016
Organic growth
Solid operational improvement
Good cash conversion
2017
Organic growth
> €100 million EBIT
Good cash conversion
Cmarel Innovation Through Partnership

Thank you
Takk fyrir
Dank u wel
Mange tak
Disclaimer
marel
Innovation Through Partnership
This Presentation is being furnished for the sole purpose of assisting the recipient in deciding whether to proceed with further analysis of this potential opportunity. This Presentation is for informational purposes only and shall not be construed as an offer or solicitation for the subscription or purchase or sale of any securities, or as an invitation, inducement or intermediation for the sale, subscription or purchase of securities.
The information set out in this Presentation may be subject to updating, completion, revision and amendment and such information may change materially. Even though Marel hf. has given due care and attention in the preparation of this Presentation, no representation or warranty, express or implied, is or will be made by Marel hf. as to the accuracy, completeness or fairness of the information or opinions contained in this Presentation and any reliance the recipient places on them will be at its own sole risk. Without prejudice to the foregoing, Marel hf. does not accept any liability whatsoever for any loss howsoever arising, directly or indirectly, from use of this Presentation or its contents or otherwise arising in connection therewith. Any recipient of this Presentation is recommended to seek its own financial advice.
There is no representation, warranty or other assurance that any of the projections in the Presentation will be realized. The recipient should conduct its own investigation and analysis of the business, data and property described herein. Any statement contained in this Presentation that refers to estimated or anticipated future results or future activities are forward-looking statements which reflect current analysis of existing trends, information and plans. Forward-looking statements are subject to a number of risks and uncertainties that could cause actual results to differ materially and could adversely affect the outcome and financial effects of the plans and events described herein. As a result, the recipient is cautioned not to place undue reliance on such forward-looking statements.
Transactions with financial instruments by their very nature involve high risk. Historical price changes are not necessarily an indication of future price trends. Any recipient of this Presentation are encouraged to acquire general information from expert advisors concerning securities trading, investment issues, taxation, etc. in connection with securities transactions.
This Presentation and its contents are confidential and may not be further distributed, published or reproduced, in whole or in part, by any medium or in any form for any purpose, without the express written consent of Marel hf. By accepting this Presentation the recipient has agreed, upon request, to return promptly all material received from Marel hf. (including this Presentation) without retaining any copies. In furnishing this Presentation, Marel hf. undertakes no obligation to provide the recipient with access to any additional information or to update this Presentation or to correct any inaccuracies therein which may become apparent.
The distribution of this Presentation, or any of the information contained in it, in other jurisdictions than the Republic of Iceland may be restricted by law, and persons into whose possession this Presentation comes should inform themselves about, and observe, any such restrictions. Any failure to comply with these restrictions may constitute a violation of the laws of any such other jurisdictions.